Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -7.29% is 77% above its 5-year average of -32.13%, near the high end of its 5-year range (-114.34%–15.98%).
As of the fiscal period ended Wednesday, December 31, 2025. 56.80% above its 12-month average of -16.88%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2025 (2025-12-31): -1.65%.
RETURN ON ASSETS (ROA)
-7.29%
RETURN ON ASSETS (ROA) AVG TTM
-16.88%
RETURN ON ASSETS (ROA) AVG 3Y
-23.60%
RETURN ON ASSETS (ROA) AVG 5Y
-32.13%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+56.80%
CURRENT VS 3Y AVG
+69.11%
CURRENT VS 5Y AVG
+77.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+77.41%
vs the sector median at left
Niki BioSolutions, Inc.
Market Cap
$403887.00
Return on Assets (ROA)
-7.29%
TTM Avg
-16.88%
3Y Avg
-23.60%
5Y Avg
-32.13%
Market Cap
$378849.00
Return on Assets (ROA)
-60.35%
TTM Avg
-77.33%
3Y Avg
-83.27%
5Y Avg
-755.53%
Market Cap
$481786.00
Return on Assets (ROA)
-60.68%
TTM Avg
-88.11%
3Y Avg
-75.03%
5Y Avg
-60.97%
Market Cap
$518606.00
Return on Assets (ROA)
-320.72%
TTM Avg
-102.20%
3Y Avg
-130.11%
5Y Avg
-99.50%
Market Cap
$545796.00
Return on Assets (ROA)
-18.39%
TTM Avg
-65.88%
3Y Avg
-62.81%
5Y Avg
-52.14%
Market Cap
$250443.00
Return on Assets (ROA)
-159.79%
TTM Avg
-110.26%
3Y Avg
-72.69%
5Y Avg
-81.04%
Market Cap
$667469.00
Return on Assets (ROA)
N/A
TTM Avg
-16.55%
3Y Avg
-16.64%
5Y Avg
-15.27%
Market Cap
$110112.00
Return on Assets (ROA)
-328.73%
TTM Avg
-369.72%
3Y Avg
-216.98%
5Y Avg
-169.99%
Market Cap
$95475.00
Return on Assets (ROA)
N/A
TTM Avg
-12.82%
3Y Avg
-1135.32%
5Y Avg
-756.46%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Niki BioSolutions, Inc. (NIKI) | $403887.00 | -7.29% | -16.88% | -23.60% | -32.13% |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | -60.35% | -77.33% | -83.27% | -755.53% |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | -60.68% | -88.11% | -75.03% | -60.97% |
| VivoSim Labs, Inc. (VIVS)vs › | $518606.00 | -320.72% | -102.20% | -130.11% | -99.50% |
| HCW Biologics Inc. (HCWB)vs › | $545796.00 | -18.39% | -65.88% | -62.81% | -52.14% |
| SciSparc Ltd. (SPRC)vs › | $250443.00 | -159.79% | -110.26% | -72.69% | -81.04% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | N/A | -16.55% | -16.64% | -15.27% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $110112.00 | -328.73% | -369.72% | -216.98% | -169.99% |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | N/A | -12.82% | -1135.32% | -756.46% |
| CDT Equity Inc. (CDT)vs › | $716854.00 | 2.60% | -212.84% | -24543.27% | -19977.79% |
ROA
-7.3%
ROE
-5.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -7.29% |
| 2024-12-31 | -26.46% |
| 2023-12-31 | -13.69% |
| 2022-12-31 | -46.96% |
| 2021-12-31 | -114.34% |
| 2020-12-31 | 15.98% |
| 2019-12-31 | -78.01% |
| 2018-12-31 | -32.91% |
| 2017-12-31 | -8.07% |
